EVOK Evoke Pharma Inc

Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.

$0.60  -0.06 (-9.67%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  09/25/2013
Outstanding shares:  32,656,480
Average volume:  313,222
Market cap:   $21,621,855
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30049G104
ISIN:        US30049G1040
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.14
PB ratio:   4.10
PS ratio:   16.89
Return on equity:   -191.35%
Net income %:   -713.26%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy